Lewis L. Lanier

Research interests

Publications

• Multiple early factors anticipate post-acute COVID-19 sequelae

  Cell · 2022 · https://doi.org/10.1016/j.cell.2022.01.014

• Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

  Cell · 2020 · https://doi.org/10.1016/j.cell.2020.10.037

• Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients

  Nature Biotechnology · 2019 · 10.1038/s41587-019-0016-3

• NK cells and cancer: you can teach innate cells new tricks

  Nature reviews. Cancer · 2015 · 10.1038/nrc.2015.5

• Expansion of a unique CD57 + NKG2C hi natural killer cell subset during acute human cytomegalovirus infection

  Proceedings of the National Academy of Sciences · 2011 · 10.1073/pnas.1110900108

• Innate or Adaptive Immunity? The Example of Natural Killer Cells

  Science · 2011 · https://doi.org/10.1126/science.1198687

• CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset

  Blood · 2010 · 10.1182/blood-2010-04-282301

• Adaptive immune features of natural killer cells

  Nature · 2009 · 10.1038/nature07665

• The Immunological Genome Project: networks of gene expression in immune cells

  Nature Immunology · 2008 · https://doi.org/10.1038/ni1008-1091

• Up on the tightrope: natural killer cell activation and inhibition

  Nature Immunology · 2008 · 10.1038/ni1581

• CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs

  Nature · 2006 · 10.1038/nature04606

• NK CELL RECOGNITION

  Annual Review of Immunology · 2004 · https://doi.org/10.1146/annurev.immunol.23.021704.115526

• Coordinated Induction by IL15 of a TCR-Independent NKG2D Signaling Pathway Converts CTL into Lymphokine-Activated Killer Cells in Celiac Disease

  Immunity · 2004 · 10.1016/j.immuni.2004.06.020

• Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors

  Science · 2002 · 10.1126/science.1070884

• Natural killer cells, viruses and cancer

  Nature reviews. Immunology · 2001 · 10.1038/35095564

• Immune Inhibitory Receptors

  Science · 2000 · 10.1126/science.290.5489.84

• An Activating Immunoreceptor Complex Formed by NKG2D and DAP10

  Science · 1999 · 10.1126/science.285.5428.730

• Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA

  Science · 1999 · 10.1126/science.285.5428.727

• Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells

  Nature · 1998 · 10.1038/35642

• NK CELL RECEPTORS

  Annual Review of Immunology · 1998 · 10.1146/annurev.immunol.16.1.359

• HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

  Nature · 1998 · 10.1038/35869

• Functionally and Structurally Distinct NK Cell Receptor Repertoires in the Peripheral Blood of Two Human Donors

  Immunity · 1997 · 10.1016/s1074-7613(00)80393-3

• Human Diversity in Killer Cell Inhibitory Receptor Genes

  Immunity · 1997 · 10.1016/s1074-7613(00)80394-5

• B70 antigen is a second ligand for CTLA-4 and CD28

  Nature · 1993 · 10.1038/366076a0

• The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.

  The Journal of Immunology · 1986 · 10.4049/jimmunol.136.12.4480

• Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.

  The Journal of Immunology · 1983 · 10.4049/jimmunol.131.4.1789

Current projects

No projects listed.